Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

OPG Power Ventures (OPG): Management succession and update
OPG Power Ventures (OPG): Management succession and update
OPG Power Ventures (OPG): Management succession and update
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
Biophytis provides updates on Sarconeos (BIO101) clinical development
Biophytis provides updates on Sarconeos (BIO101) clinical development
Biophytis provides updates on Sarconeos (BIO101) clinical development
DGAP-News: Multitude SE is contemplating a subsequent bond issue
DGAP-News: Multitude SE is contemplating a subsequent bond issue
DGAP-News: Multitude SE is contemplating a subsequent bond issue
Travis Perkins: Transaction in Own Shares
Travis Perkins: Transaction in Own Shares
Travis Perkins: Transaction in Own Shares
Biophytis Announces 2021 Operational and Financial Results and Gives Updates on 2022 perspectives
Biophytis Announces 2021 Operational and Financial Results and Gives Updates on 2022 perspectives
Biophytis Announces 2021 Operational and Financial Results and Gives Updates on 2022 perspectives
DGAP-News: BAUER Aktiengesellschaft: BAUER AG achieves an increase in total Group revenues for 2021 despite challenging market conditions
DGAP-News: BAUER Aktiengesellschaft: BAUER AG achieves an increase in total Group revenues for 2021 despite challenging market conditions
DGAP-News: BAUER Aktiengesellschaft: BAUER AG achieves an increase in total Group revenues for 2021 despite challenging market conditions
ASMALLWORLD AG invites shareholders to the Annual General Meeting
ASMALLWORLD AG invites shareholders to the Annual General Meeting
ASMALLWORLD AG invites shareholders to the Annual General Meeting
Baloise shares its know-how with start-up founders
Baloise shares its know-how with start-up founders
Baloise shares its know-how with start-up founders
DGAP-News: NFON AG repositions itself in the growing market for integrated business communications
DGAP-News: NFON AG repositions itself in the growing market for integrated business communications
DGAP-News: NFON AG repositions itself in the growing market for integrated business communications
Ad-hoc announcement pursuant to Art. 53 LR: Jungfrau Railway Group achieves virtually break-even result
Ad-hoc announcement pursuant to Art. 53 LR: Jungfrau Railway Group achieves virtually break-even result
Ad-hoc announcement pursuant to Art. 53 LR: Jungfrau Railway Group achieves virtually break-even result
DGAP-Adhoc: ​​​​​​​Eckert & Ziegler Publishes Preliminary Figures for Q1/2022 with Deviation in Earnings and Confirms Annual Forecast for 2022
DGAP-Adhoc: ​​​​​​​Eckert & Ziegler Publishes Preliminary Figures for Q1/2022 with Deviation in Earnings and Confirms Annual Forecast for 2022
DGAP-Adhoc: ​​​​​​​Eckert & Ziegler Publishes Preliminary Figures for Q1/2022 with Deviation in Earnings and Confirms Annual Forecast for 2022
DGAP-Adhoc: Enapter AG: Announcement Capital Increase
DGAP-Adhoc: Enapter AG: Announcement Capital Increase
DGAP-Adhoc: Enapter AG: Announcement Capital Increase
Rights and Issues Investment Trust PLC: POS-Transaction in Own Shares
Rights and Issues Investment Trust PLC: POS-Transaction in Own Shares
Rights and Issues Investment Trust PLC: POS-Transaction in Own Shares
GEVELOT S.A.: PRESS RELEASE CLOSING OF 2021 ACCOUNTS
GEVELOT S.A.: PRESS RELEASE CLOSING OF 2021 ACCOUNTS
GEVELOT S.A.: PRESS RELEASE CLOSING OF 2021 ACCOUNTS
DGAP-News: Abivax reports excellent one-year efficacy and safety data of ABX464 phase 2b maintenance trial in ulcerative colitis
DGAP-News: Abivax reports excellent one-year efficacy and safety data of ABX464 phase 2b maintenance trial in ulcerative colitis
DGAP-News: Abivax reports excellent one-year efficacy and safety data of ABX464 phase 2b maintenance trial in ulcerative colitis
ENERGISME: Results 2021 - Revenues of €3.46 million, up 71% from 2020.
ENERGISME: Results 2021 - Revenues of €3.46 million, up 71% from 2020.
ENERGISME: Results 2021 - Revenues of €3.46 million, up 71% from 2020.
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
DGAP-Adhoc: InCity Immobilien AG: ON THE BASIS OF INTERIM FIGURES FOR 2021, INCITY ACHIEVES A CONSOLIDATED NET INCOME OF APPROX. EUR 1.0 M AND A NET INCOME OF APPROX. EUR 2.1 M IN THE SINGLE-ENTITY COMPANY
DGAP-Adhoc: InCity Immobilien AG: ON THE BASIS OF INTERIM FIGURES FOR 2021, INCITY ACHIEVES A CONSOLIDATED NET INCOME OF APPROX. EUR 1.0 M AND A NET INCOME OF APPROX. EUR 2.1 M IN THE SINGLE-ENTITY COMPANY
DGAP-Adhoc: InCity Immobilien AG: ON THE BASIS OF INTERIM FIGURES FOR 2021, INCITY ACHIEVES A CONSOLIDATED NET INCOME OF APPROX. EUR 1.0 M AND A NET INCOME OF APPROX. EUR 2.1 M IN THE SINGLE-ENTITY COMPANY
DGAP-News: Burcon Receives NASDAQ Letter Regarding Minimum Bid Price Deficiency
DGAP-News: Burcon Receives NASDAQ Letter Regarding Minimum Bid Price Deficiency
DGAP-News: Burcon Receives NASDAQ Letter Regarding Minimum Bid Price Deficiency
Alzchem Group AG: International Creatine Conference 2022
Alzchem Group AG: International Creatine Conference 2022
Alzchem Group AG: International Creatine Conference 2022
WICKES GROUP PLC: Director/PDMR Shareholding
WICKES GROUP PLC: Director/PDMR Shareholding
WICKES GROUP PLC: Director/PDMR Shareholding
Form 8.3 - The Vanguard Group, Inc.: Brewin Dolphin Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Brewin Dolphin Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Brewin Dolphin Holdings plc
Form 8.3 - The Vanguard Group, Inc.: GXO Logistics, Inc
Form 8.3 - The Vanguard Group, Inc.: GXO Logistics, Inc
Form 8.3 - The Vanguard Group, Inc.: GXO Logistics, Inc
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc